nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0775	0.178	CbGbCtD
Paroxetine—CYP2B6—Dexamethasone—psoriatic arthritis	0.0572	0.131	CbGbCtD
Paroxetine—ABCB1—Betamethasone—psoriatic arthritis	0.0504	0.116	CbGbCtD
Paroxetine—ABCB1—Prednisolone—psoriatic arthritis	0.0497	0.114	CbGbCtD
Paroxetine—ABCB1—Prednisone—psoriatic arthritis	0.047	0.108	CbGbCtD
Paroxetine—CYP2C8—Dexamethasone—psoriatic arthritis	0.0433	0.0994	CbGbCtD
Paroxetine—CYP2C9—Dexamethasone—psoriatic arthritis	0.0302	0.0693	CbGbCtD
Paroxetine—ABCB1—Dexamethasone—psoriatic arthritis	0.0293	0.0673	CbGbCtD
Paroxetine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0276	0.0634	CbGbCtD
Paroxetine—ABCB1—Methotrexate—psoriatic arthritis	0.0236	0.0541	CbGbCtD
Paroxetine—Shock—Triamcinolone—psoriatic arthritis	0.00029	0.000513	CcSEcCtD
Paroxetine—Insomnia—Prednisolone—psoriatic arthritis	0.00029	0.000513	CcSEcCtD
Paroxetine—Alopecia—Prednisone—psoriatic arthritis	0.000289	0.000513	CcSEcCtD
Paroxetine—Shock—Methylprednisolone—psoriatic arthritis	0.000289	0.000512	CcSEcCtD
Paroxetine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000288	0.000511	CcSEcCtD
Paroxetine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000288	0.000511	CcSEcCtD
Paroxetine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000288	0.00051	CcSEcCtD
Paroxetine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000288	0.00051	CcSEcCtD
Paroxetine—Epistaxis—Methotrexate—psoriatic arthritis	0.000288	0.00051	CcSEcCtD
Paroxetine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000288	0.00051	CcSEcCtD
Paroxetine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000287	0.000509	CcSEcCtD
Paroxetine—Mental disorder—Prednisone—psoriatic arthritis	0.000287	0.000509	CcSEcCtD
Paroxetine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000287	0.000508	CcSEcCtD
Paroxetine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000285	0.000506	CcSEcCtD
Paroxetine—Erythema—Prednisone—psoriatic arthritis	0.000285	0.000505	CcSEcCtD
Paroxetine—Malnutrition—Prednisone—psoriatic arthritis	0.000285	0.000505	CcSEcCtD
Paroxetine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000285	0.000505	CcSEcCtD
Paroxetine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000285	0.000504	CcSEcCtD
Paroxetine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000284	0.000503	CcSEcCtD
Paroxetine—Convulsion—Dexamethasone—psoriatic arthritis	0.000284	0.000503	CcSEcCtD
Paroxetine—Convulsion—Betamethasone—psoriatic arthritis	0.000284	0.000503	CcSEcCtD
Paroxetine—Hypertension—Dexamethasone—psoriatic arthritis	0.000283	0.000501	CcSEcCtD
Paroxetine—Hypertension—Betamethasone—psoriatic arthritis	0.000283	0.000501	CcSEcCtD
Paroxetine—Myalgia—Dexamethasone—psoriatic arthritis	0.000279	0.000494	CcSEcCtD
Paroxetine—Myalgia—Betamethasone—psoriatic arthritis	0.000279	0.000494	CcSEcCtD
Paroxetine—Anxiety—Betamethasone—psoriatic arthritis	0.000278	0.000492	CcSEcCtD
Paroxetine—Anxiety—Dexamethasone—psoriatic arthritis	0.000278	0.000492	CcSEcCtD
Paroxetine—Discomfort—Betamethasone—psoriatic arthritis	0.000275	0.000488	CcSEcCtD
Paroxetine—Discomfort—Dexamethasone—psoriatic arthritis	0.000275	0.000488	CcSEcCtD
Paroxetine—Haemoglobin—Methotrexate—psoriatic arthritis	0.000275	0.000488	CcSEcCtD
Paroxetine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000275	0.000487	CcSEcCtD
Paroxetine—Pain—Prednisolone—psoriatic arthritis	0.000274	0.000485	CcSEcCtD
Paroxetine—Haemorrhage—Methotrexate—psoriatic arthritis	0.000274	0.000485	CcSEcCtD
Paroxetine—Hepatitis—Methotrexate—psoriatic arthritis	0.000274	0.000485	CcSEcCtD
Paroxetine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000272	0.000481	CcSEcCtD
Paroxetine—Vision blurred—Prednisone—psoriatic arthritis	0.000269	0.000476	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000268	0.000475	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000268	0.000474	CcSEcCtD
Paroxetine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000267	0.000474	CcSEcCtD
Paroxetine—Oedema—Betamethasone—psoriatic arthritis	0.000267	0.000474	CcSEcCtD
Paroxetine—Oedema—Dexamethasone—psoriatic arthritis	0.000267	0.000474	CcSEcCtD
Paroxetine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000267	0.000474	CcSEcCtD
Paroxetine—Insomnia—Triamcinolone—psoriatic arthritis	0.000266	0.000472	CcSEcCtD
Paroxetine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000266	0.000471	CcSEcCtD
Paroxetine—Infection—Dexamethasone—psoriatic arthritis	0.000265	0.00047	CcSEcCtD
Paroxetine—Infection—Betamethasone—psoriatic arthritis	0.000265	0.00047	CcSEcCtD
Paroxetine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000265	0.000469	CcSEcCtD
Paroxetine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000264	0.000469	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000264	0.000468	CcSEcCtD
Paroxetine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000264	0.000468	CcSEcCtD
Paroxetine—Visual impairment—Methotrexate—psoriatic arthritis	0.000264	0.000468	CcSEcCtD
Paroxetine—Anaemia—Prednisone—psoriatic arthritis	0.000264	0.000467	CcSEcCtD
Paroxetine—Shock—Betamethasone—psoriatic arthritis	0.000263	0.000466	CcSEcCtD
Paroxetine—Shock—Dexamethasone—psoriatic arthritis	0.000263	0.000466	CcSEcCtD
Paroxetine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000263	0.000465	CcSEcCtD
Paroxetine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000262	0.000464	CcSEcCtD
Paroxetine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000262	0.000464	CcSEcCtD
Paroxetine—Agitation—Prednisone—psoriatic arthritis	0.000262	0.000464	CcSEcCtD
Paroxetine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000262	0.000464	CcSEcCtD
Paroxetine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000262	0.000464	CcSEcCtD
Paroxetine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000261	0.000462	CcSEcCtD
Paroxetine—Tachycardia—Betamethasone—psoriatic arthritis	0.000261	0.000462	CcSEcCtD
Paroxetine—Angioedema—Prednisone—psoriatic arthritis	0.000261	0.000462	CcSEcCtD
Paroxetine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000259	0.000459	CcSEcCtD
Paroxetine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000259	0.000459	CcSEcCtD
Paroxetine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000259	0.000458	CcSEcCtD
Paroxetine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000258	0.000458	CcSEcCtD
Paroxetine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000258	0.000458	CcSEcCtD
Paroxetine—Malaise—Prednisone—psoriatic arthritis	0.000257	0.000456	CcSEcCtD
Paroxetine—Vertigo—Prednisone—psoriatic arthritis	0.000256	0.000454	CcSEcCtD
Paroxetine—Eye disorder—Methotrexate—psoriatic arthritis	0.000256	0.000453	CcSEcCtD
Paroxetine—Syncope—Prednisone—psoriatic arthritis	0.000256	0.000453	CcSEcCtD
Paroxetine—Tinnitus—Methotrexate—psoriatic arthritis	0.000255	0.000452	CcSEcCtD
Paroxetine—Urticaria—Prednisolone—psoriatic arthritis	0.000254	0.000451	CcSEcCtD
Paroxetine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000254	0.00045	CcSEcCtD
Paroxetine—Fatigue—Triamcinolone—psoriatic arthritis	0.000254	0.00045	CcSEcCtD
Paroxetine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000253	0.000449	CcSEcCtD
Paroxetine—Pain—Triamcinolone—psoriatic arthritis	0.000252	0.000446	CcSEcCtD
Paroxetine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000251	0.000444	CcSEcCtD
Paroxetine—Hypotension—Dexamethasone—psoriatic arthritis	0.00025	0.000442	CcSEcCtD
Paroxetine—Hypotension—Betamethasone—psoriatic arthritis	0.00025	0.000442	CcSEcCtD
Paroxetine—Angiopathy—Methotrexate—psoriatic arthritis	0.000248	0.00044	CcSEcCtD
Paroxetine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000247	0.000438	CcSEcCtD
Paroxetine—Convulsion—Prednisone—psoriatic arthritis	0.000247	0.000438	CcSEcCtD
Paroxetine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000247	0.000437	CcSEcCtD
Paroxetine—Hypertension—Prednisone—psoriatic arthritis	0.000246	0.000436	CcSEcCtD
Paroxetine—Chills—Methotrexate—psoriatic arthritis	0.000246	0.000435	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000243	0.000431	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000243	0.000431	CcSEcCtD
Paroxetine—Myalgia—Prednisone—psoriatic arthritis	0.000243	0.00043	CcSEcCtD
Paroxetine—Arthralgia—Prednisone—psoriatic arthritis	0.000243	0.00043	CcSEcCtD
Paroxetine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000243	0.00043	CcSEcCtD
Paroxetine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000242	0.000429	CcSEcCtD
Paroxetine—Anxiety—Prednisone—psoriatic arthritis	0.000242	0.000429	CcSEcCtD
Paroxetine—Alopecia—Methotrexate—psoriatic arthritis	0.000242	0.000429	CcSEcCtD
Paroxetine—Insomnia—Betamethasone—psoriatic arthritis	0.000242	0.000428	CcSEcCtD
Paroxetine—Insomnia—Dexamethasone—psoriatic arthritis	0.000242	0.000428	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000241	0.000427	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00024	0.000426	CcSEcCtD
Paroxetine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00024	0.000425	CcSEcCtD
Paroxetine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00024	0.000425	CcSEcCtD
Paroxetine—Discomfort—Prednisone—psoriatic arthritis	0.00024	0.000425	CcSEcCtD
Paroxetine—Mental disorder—Methotrexate—psoriatic arthritis	0.00024	0.000425	CcSEcCtD
Paroxetine—Erythema—Methotrexate—psoriatic arthritis	0.000238	0.000422	CcSEcCtD
Paroxetine—Malnutrition—Methotrexate—psoriatic arthritis	0.000238	0.000422	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000236	0.000418	CcSEcCtD
Paroxetine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000235	0.000417	CcSEcCtD
Paroxetine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000235	0.000417	CcSEcCtD
Paroxetine—Urticaria—Triamcinolone—psoriatic arthritis	0.000234	0.000415	CcSEcCtD
Paroxetine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000233	0.000414	CcSEcCtD
Paroxetine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000233	0.000414	CcSEcCtD
Paroxetine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000233	0.000413	CcSEcCtD
Paroxetine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000233	0.000412	CcSEcCtD
Paroxetine—Oedema—Prednisone—psoriatic arthritis	0.000233	0.000412	CcSEcCtD
Paroxetine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000232	0.000412	CcSEcCtD
Paroxetine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000232	0.000412	CcSEcCtD
Paroxetine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000232	0.000412	CcSEcCtD
Paroxetine—Infection—Prednisone—psoriatic arthritis	0.000231	0.00041	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000231	0.000409	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000231	0.000409	CcSEcCtD
Paroxetine—Back pain—Methotrexate—psoriatic arthritis	0.00023	0.000408	CcSEcCtD
Paroxetine—Fatigue—Dexamethasone—psoriatic arthritis	0.00023	0.000408	CcSEcCtD
Paroxetine—Fatigue—Betamethasone—psoriatic arthritis	0.00023	0.000408	CcSEcCtD
Paroxetine—Shock—Prednisone—psoriatic arthritis	0.000229	0.000406	CcSEcCtD
Paroxetine—Pain—Betamethasone—psoriatic arthritis	0.000228	0.000405	CcSEcCtD
Paroxetine—Pain—Dexamethasone—psoriatic arthritis	0.000228	0.000405	CcSEcCtD
Paroxetine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000228	0.000404	CcSEcCtD
Paroxetine—Tachycardia—Prednisone—psoriatic arthritis	0.000227	0.000402	CcSEcCtD
Paroxetine—Skin disorder—Prednisone—psoriatic arthritis	0.000226	0.000401	CcSEcCtD
Paroxetine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000225	0.000399	CcSEcCtD
Paroxetine—Vision blurred—Methotrexate—psoriatic arthritis	0.000225	0.000398	CcSEcCtD
Paroxetine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000221	0.000392	CcSEcCtD
Paroxetine—Anaemia—Methotrexate—psoriatic arthritis	0.00022	0.00039	CcSEcCtD
Paroxetine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00022	0.00039	CcSEcCtD
Paroxetine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00022	0.00039	CcSEcCtD
Paroxetine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000218	0.000387	CcSEcCtD
Paroxetine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000218	0.000387	CcSEcCtD
Paroxetine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000217	0.000385	CcSEcCtD
Paroxetine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000216	0.000384	CcSEcCtD
Paroxetine—Malaise—Methotrexate—psoriatic arthritis	0.000215	0.000381	CcSEcCtD
Paroxetine—Vertigo—Methotrexate—psoriatic arthritis	0.000214	0.000379	CcSEcCtD
Paroxetine—Leukopenia—Methotrexate—psoriatic arthritis	0.000213	0.000378	CcSEcCtD
Paroxetine—Urticaria—Betamethasone—psoriatic arthritis	0.000212	0.000376	CcSEcCtD
Paroxetine—Urticaria—Dexamethasone—psoriatic arthritis	0.000212	0.000376	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000212	0.000376	CcSEcCtD
Paroxetine—Dizziness—Prednisolone—psoriatic arthritis	0.000212	0.000375	CcSEcCtD
Paroxetine—Asthenia—Triamcinolone—psoriatic arthritis	0.000211	0.000374	CcSEcCtD
Paroxetine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000211	0.000374	CcSEcCtD
Paroxetine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000211	0.000374	CcSEcCtD
Paroxetine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000211	0.000374	CcSEcCtD
Paroxetine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000211	0.000374	CcSEcCtD
Paroxetine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000211	0.000374	CcSEcCtD
Paroxetine—Insomnia—Prednisone—psoriatic arthritis	0.00021	0.000373	CcSEcCtD
Paroxetine—Paraesthesia—Prednisone—psoriatic arthritis	0.000209	0.00037	CcSEcCtD
Paroxetine—Pruritus—Triamcinolone—psoriatic arthritis	0.000208	0.000369	CcSEcCtD
Paroxetine—Cough—Methotrexate—psoriatic arthritis	0.000208	0.000369	CcSEcCtD
Paroxetine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000208	0.000368	CcSEcCtD
Paroxetine—Convulsion—Methotrexate—psoriatic arthritis	0.000206	0.000366	CcSEcCtD
Paroxetine—Dyspepsia—Prednisone—psoriatic arthritis	0.000205	0.000363	CcSEcCtD
Paroxetine—Myalgia—Methotrexate—psoriatic arthritis	0.000203	0.00036	CcSEcCtD
Paroxetine—Arthralgia—Methotrexate—psoriatic arthritis	0.000203	0.00036	CcSEcCtD
Paroxetine—Chest pain—Methotrexate—psoriatic arthritis	0.000203	0.00036	CcSEcCtD
Paroxetine—Decreased appetite—Prednisone—psoriatic arthritis	0.000202	0.000358	CcSEcCtD
Paroxetine—Rash—Prednisolone—psoriatic arthritis	0.000202	0.000358	CcSEcCtD
Paroxetine—Dermatitis—Prednisolone—psoriatic arthritis	0.000202	0.000358	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000201	0.000357	CcSEcCtD
Paroxetine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000201	0.000356	CcSEcCtD
Paroxetine—Fatigue—Prednisone—psoriatic arthritis	0.000201	0.000356	CcSEcCtD
Paroxetine—Headache—Prednisolone—psoriatic arthritis	0.000201	0.000356	CcSEcCtD
Paroxetine—Discomfort—Methotrexate—psoriatic arthritis	0.0002	0.000355	CcSEcCtD
Paroxetine—Constipation—Prednisone—psoriatic arthritis	0.000199	0.000353	CcSEcCtD
Paroxetine—Confusional state—Methotrexate—psoriatic arthritis	0.000196	0.000348	CcSEcCtD
Paroxetine—Dizziness—Triamcinolone—psoriatic arthritis	0.000195	0.000345	CcSEcCtD
Paroxetine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000194	0.000345	CcSEcCtD
Paroxetine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000194	0.000344	CcSEcCtD
Paroxetine—Infection—Methotrexate—psoriatic arthritis	0.000193	0.000342	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000192	0.00034	CcSEcCtD
Paroxetine—Asthenia—Betamethasone—psoriatic arthritis	0.000192	0.00034	CcSEcCtD
Paroxetine—Asthenia—Dexamethasone—psoriatic arthritis	0.000192	0.00034	CcSEcCtD
Paroxetine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000191	0.000338	CcSEcCtD
Paroxetine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00019	0.000337	CcSEcCtD
Paroxetine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00019	0.000337	CcSEcCtD
Paroxetine—Nausea—Prednisolone—psoriatic arthritis	0.00019	0.000337	CcSEcCtD
Paroxetine—Pruritus—Betamethasone—psoriatic arthritis	0.000189	0.000335	CcSEcCtD
Paroxetine—Pruritus—Dexamethasone—psoriatic arthritis	0.000189	0.000335	CcSEcCtD
Paroxetine—Skin disorder—Methotrexate—psoriatic arthritis	0.000189	0.000335	CcSEcCtD
Paroxetine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000188	0.000333	CcSEcCtD
Paroxetine—Vomiting—Triamcinolone—psoriatic arthritis	0.000187	0.000332	CcSEcCtD
Paroxetine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000187	0.000331	CcSEcCtD
Paroxetine—Rash—Triamcinolone—psoriatic arthritis	0.000186	0.000329	CcSEcCtD
Paroxetine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000185	0.000329	CcSEcCtD
Paroxetine—Rash—Methylprednisolone—psoriatic arthritis	0.000185	0.000328	CcSEcCtD
Paroxetine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000185	0.000328	CcSEcCtD
Paroxetine—Urticaria—Prednisone—psoriatic arthritis	0.000185	0.000328	CcSEcCtD
Paroxetine—Headache—Triamcinolone—psoriatic arthritis	0.000184	0.000327	CcSEcCtD
Paroxetine—Headache—Methylprednisolone—psoriatic arthritis	0.000184	0.000326	CcSEcCtD
Paroxetine—Abdominal pain—Prednisone—psoriatic arthritis	0.000184	0.000326	CcSEcCtD
Paroxetine—Body temperature increased—Prednisone—psoriatic arthritis	0.000184	0.000326	CcSEcCtD
Paroxetine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000183	0.000324	CcSEcCtD
Paroxetine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000183	0.000324	CcSEcCtD
Paroxetine—Hypotension—Methotrexate—psoriatic arthritis	0.000182	0.000322	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000177	0.000314	CcSEcCtD
Paroxetine—Dizziness—Dexamethasone—psoriatic arthritis	0.000177	0.000313	CcSEcCtD
Paroxetine—Dizziness—Betamethasone—psoriatic arthritis	0.000177	0.000313	CcSEcCtD
Paroxetine—Insomnia—Methotrexate—psoriatic arthritis	0.000176	0.000312	CcSEcCtD
Paroxetine—Nausea—Triamcinolone—psoriatic arthritis	0.000175	0.00031	CcSEcCtD
Paroxetine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000175	0.000309	CcSEcCtD
Paroxetine—Nausea—Methylprednisolone—psoriatic arthritis	0.000175	0.000309	CcSEcCtD
Paroxetine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000173	0.000307	CcSEcCtD
Paroxetine—Somnolence—Methotrexate—psoriatic arthritis	0.000173	0.000306	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000171	0.000304	CcSEcCtD
Paroxetine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000171	0.000303	CcSEcCtD
Paroxetine—Vomiting—Betamethasone—psoriatic arthritis	0.00017	0.000301	CcSEcCtD
Paroxetine—Vomiting—Dexamethasone—psoriatic arthritis	0.00017	0.000301	CcSEcCtD
Paroxetine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000169	0.0003	CcSEcCtD
Paroxetine—Rash—Dexamethasone—psoriatic arthritis	0.000168	0.000299	CcSEcCtD
Paroxetine—Rash—Betamethasone—psoriatic arthritis	0.000168	0.000299	CcSEcCtD
Paroxetine—Dermatitis—Betamethasone—psoriatic arthritis	0.000168	0.000298	CcSEcCtD
Paroxetine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000168	0.000298	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000168	0.000298	CcSEcCtD
Paroxetine—Fatigue—Methotrexate—psoriatic arthritis	0.000168	0.000297	CcSEcCtD
Paroxetine—Headache—Betamethasone—psoriatic arthritis	0.000167	0.000297	CcSEcCtD
Paroxetine—Headache—Dexamethasone—psoriatic arthritis	0.000167	0.000297	CcSEcCtD
Paroxetine—Asthenia—Prednisone—psoriatic arthritis	0.000167	0.000296	CcSEcCtD
Paroxetine—Pain—Methotrexate—psoriatic arthritis	0.000166	0.000295	CcSEcCtD
Paroxetine—Pruritus—Prednisone—psoriatic arthritis	0.000165	0.000292	CcSEcCtD
Paroxetine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00016	0.000284	CcSEcCtD
Paroxetine—Diarrhoea—Prednisone—psoriatic arthritis	0.000159	0.000282	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000159	0.000282	CcSEcCtD
Paroxetine—Nausea—Betamethasone—psoriatic arthritis	0.000159	0.000281	CcSEcCtD
Paroxetine—Nausea—Dexamethasone—psoriatic arthritis	0.000159	0.000281	CcSEcCtD
Paroxetine—Urticaria—Methotrexate—psoriatic arthritis	0.000154	0.000274	CcSEcCtD
Paroxetine—Dizziness—Prednisone—psoriatic arthritis	0.000154	0.000273	CcSEcCtD
Paroxetine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000154	0.000272	CcSEcCtD
Paroxetine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000154	0.000272	CcSEcCtD
Paroxetine—Vomiting—Prednisone—psoriatic arthritis	0.000148	0.000262	CcSEcCtD
Paroxetine—Rash—Prednisone—psoriatic arthritis	0.000147	0.00026	CcSEcCtD
Paroxetine—Dermatitis—Prednisone—psoriatic arthritis	0.000147	0.00026	CcSEcCtD
Paroxetine—Headache—Prednisone—psoriatic arthritis	0.000146	0.000258	CcSEcCtD
Paroxetine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000143	0.000254	CcSEcCtD
Paroxetine—Asthenia—Methotrexate—psoriatic arthritis	0.00014	0.000247	CcSEcCtD
Paroxetine—Nausea—Prednisone—psoriatic arthritis	0.000138	0.000245	CcSEcCtD
Paroxetine—Pruritus—Methotrexate—psoriatic arthritis	0.000138	0.000244	CcSEcCtD
Paroxetine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000133	0.000236	CcSEcCtD
Paroxetine—Dizziness—Methotrexate—psoriatic arthritis	0.000129	0.000228	CcSEcCtD
Paroxetine—Vomiting—Methotrexate—psoriatic arthritis	0.000124	0.000219	CcSEcCtD
Paroxetine—Rash—Methotrexate—psoriatic arthritis	0.000123	0.000217	CcSEcCtD
Paroxetine—Dermatitis—Methotrexate—psoriatic arthritis	0.000122	0.000217	CcSEcCtD
Paroxetine—Headache—Methotrexate—psoriatic arthritis	0.000122	0.000216	CcSEcCtD
Paroxetine—Nausea—Methotrexate—psoriatic arthritis	0.000116	0.000205	CcSEcCtD
